Thomas Wessel van de Voort

Five decades of gene therapy innovation and regulation in the US and EU: a historical analysis.

The development of gene therapy is characterized by expectations of patient benefits, but challenges persist, including rapid technological change and, typically, small target populations. This has thus far resulted in relatively few gene therapies reaching the market and benefiting patients. Regulation plays a central...